Lipoglycopeptides [EXT] - N0000191280

Pharmacologic Class Information

Pharmacologic Code N0000191280
Pharmacologic Name Lipoglycopeptides
Pharmacologic Uses
  • lipoglycopeptide antibacterial
Pharmacologic Concept Terminology Extensions for Classification - [EXT]
Pharmacologic Concept Description A local MED-RT extension primarily with chemical classification concepts requested by FDA SPL for eventual addition to NLM MeSH, beneath the "Terminology Extensions for Classification [EXT]" concept, mapped to MeSH hierarchy concepts if possible.

NDC Products with Lipoglycopeptides

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Lipoglycopeptides [EXT].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
57970-100Dalvance Non-Proprietary Name: DalbavancinInjection, Powder, For SolutionIntravenousAllergan, Inc.ACTIVE
66220-315Vibativ Non-Proprietary Name: Telavancin HydrochlorideInjection, Powder, Lyophilized, For SolutionIntravenousCumberland Pharmaceuticals Inc.ACTIVE